Technical Analysis for APLT - Applied Therapeutics, Inc.

Grade Last Price % Change Price Change
F 16.79 1.08% 0.18
APLT closed up 1.08 percent on Thursday, April 15, 2021, on 31 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical APLT trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Doji - Bearish? Reversal 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.08%
Wide Bands Range Expansion 1.08%
Oversold Stochastic Weakness 1.08%
Older End-of-Day Signals for APLT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Resistance about 22 hours ago
Rose Above Previous Day's High about 22 hours ago
Rose Above 10 DMA about 22 hours ago
Outside Day about 22 hours ago
Down 1% about 22 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy. The company’s preclinical stage products include AT-001 for acute myocardial infraction; AT-007 for treating galactosemia; AT-003 to treat diabetic retinopathy; and AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Diabetes Cardiovascular Disease Diabetes Mellitus Diabetic Retinopathy Myopathy Retinopathy Cardiomyopathy Preclinical Stage Product Stage Products Novel Products Diabetic Peripheral Neuropathy Lactose Peripheral Neuropathy Preclinical Stage Products

Is APLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 51.99
52 Week Low 13.58
Average Volume 134,143
200-Day Moving Average 22.59
50-Day Moving Average 20.40
20-Day Moving Average 18.25
10-Day Moving Average 16.88
Average True Range 1.32
ADX 13.89
+DI 16.36
-DI 20.52
Chandelier Exit (Long, 3 ATRs ) 18.61
Chandelier Exit (Short, 3 ATRs ) 20.07
Upper Bollinger Band 21.34
Lower Bollinger Band 15.16
Percent B (%b) 0.26
BandWidth 33.85
MACD Line -1.02
MACD Signal Line -0.96
MACD Histogram -0.0618
Fundamentals Value
Market Cap 377.58 Million
Num Shares 22.5 Million
EPS -3.69
Price-to-Earnings (P/E) Ratio -4.56
Price-to-Sales 0.00
Price-to-Book 4.55
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.59
Resistance 3 (R3) 18.64 18.08 18.29
Resistance 2 (R2) 18.08 17.62 18.06 18.19
Resistance 1 (R1) 17.44 17.34 17.76 17.39 18.09
Pivot Point 16.88 16.88 17.05 16.86 16.88
Support 1 (S1) 16.24 16.42 16.56 16.19 15.49
Support 2 (S2) 15.68 16.14 15.66 15.39
Support 3 (S3) 15.04 15.68 15.29
Support 4 (S4) 14.99